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Abstract
The frequency of inherited bilateral autosomal recessive non-syndromic hearing loss (ARNSHL) in Pakistan is 1.6/1000
individuals. More than 50% of the families carry mutations in GJB2 while mutations in MYO15A account for about 5% of
recessive deafness. In the present study a cohort of 30 ARNSHL families was initially screened for mutations in GJB2 and
MYO15A. Homozygosity mapping was performed by employing whole genome single nucleotide polymorphism (SNP)
genotyping in the families that did not carry mutations in GJB2 or MYO15A. Mutation analysis was performed for the known
ARNSHL genes present in the homozygous regions to determine the causative mutations. This allowed the identification of
a causative mutation in all the 30 families including 9 novel mutations, which were identified in 9 different families (GJB2
(c.598G.A, p.Gly200Arg); MYO15A (c.9948G.A, p.Gln3316Gln; c.3866+1G.A; c.8767C.T, p.Arg2923* and c.8222T.C,
p.Phe2741Ser), TMC1 (c.362+18A.G), BSND (c.97G.C, p.Val33Leu), TMPRSS3 (c.726C.G, p.Cys242Trp) and MSRB3 (c.20T.G,
p.Leu7Arg)). Furthermore, 12 recurrent mutations were detected in 21 other families. The 21 identified mutations included
10 (48%) missense changes, 4 (19%) nonsense mutations, 3 (14%) intronic mutations, 2 (9%) splice site mutations and 2 (9%)
frameshift mutations. GJB2 accounted for 53% of the families, while mutations in MYO15A were the second most frequent
(13%) cause of ARNSHL in these 30 families. The identification of novel as well as recurrent mutations in the present study
increases the spectrum of mutations in known deafness genes which could lead to the identification of novel founder
mutations and population specific mutated deafness genes causative of ARNSHL. These results provide detailed genetic
information that has potential diagnostic implication in the establishment of cost-efficient allele-specific analysis of
frequently occurring variants in combination with other reported mutations in Pakistani populations.
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Introduction
Deafness or hearing loss is the most common congenital
sensorineural disorder affecting about 1 in 1000 children. Genetic
factors contribute to approximately half of the cases of hearing loss
[1], which can be either syndromic or non-syndromic. The former
is responsible for about 30% of prelingual deafness in combination
with abnormalities of other organs. Non-syndromic deafness is
usually due to abnormalities of the middle and/or the inner ear
and is found in 70% of the hereditary cases [2]. The disease is
genetically heterogeneous and currently 134 loci have been
determined and 80 genes identified for the non-syndromic type
(Hereditary Hearing Loss Homepage, URL: http://
hereditaryhearingloss.org/). More than 400 syndromes are known
with deafness as one of the symptoms and for many of these the
causative genes have been identified (Online Mendelian Inheri-
tance in Man: http://www.ncbi.nlm.nih.gov/omim).
Syndromic and non-syndromic hearing loss display an autoso-
mal recessive, autosomal dominant, X-linked, Y-linked or
mitochondrial pattern of inheritance [3]. Eighty percent of the
early onset non-syndromic cases have an autosomal recessive
inheritance pattern (ARNSHL), while autosomal dominant,
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X-linked and mitochondrial non-syndromic deafness contribute to
18%, 1–3% and ,1% of the cases, respectively [4]. In Pakistan,
hearing impairment is severe and congenital in 70% of the cases
and the increased occurrence of these conditions is due to a high
rate of consanguineous marriages (60%); profound bilateral
deafness occurs at 1.6 per 1000 individuals [5].
The genes most frequently involved in ARNSHL are those
encoding gap junction protein beta 2 (GJB2, MIM# 121011),
myosin XVA (MYO15A, MIM# 602666), transmembrane chan-
nel-like 1 (TMC1, MIM# 606706), solute carrier family 26 (anion
exchanger) member 4 (SLC26A4, MIM# 605646), otoferlin
(OTOF, MIM# 603681) and cadherin-related 23 (CDH23, MIM#
605516), each of which has been found to contain more than 20
different mutations, most of which have been reported in
consanguineous families [6]. Mutations in GJB2 are the most
common cause of ARNSHL and explain up to 50% cases in the
Mediterranean regions [7,8,9] while mutations in multiple genes
have been shown to cause deafness in the remaining cases. In the
Pakistani population mutations in MYO15A account for 5% of the
recessive deafness [10].
In the present study a panel of 30 unrelated consanguineous
Pakistani families was initially tested for involvement of GJB2 and
MYO15A followed by whole genome homozygosity mapping and
candidate gene sequencing. This approach resulted in defining the
mutation spectrum of the disease in the current panel.
Materials and Methods
Ethics statement
The current study conformed to the tenets of the Helsinki
declaration and was approved by the Department of Biosciences
Ethics Review Board of the COMSATS Institute of Information
Technology, Islamabad, Pakistan. All patients, their normal
hearing family members and 89 ethnically matched control
individuals were informed about the purpose of the study and
written consent was taken before recruitment and sampling.
Informed written consent of minors was obtained from their
guardians.
Genotyping
A total of 30 consanguineous families with ARNSHL were
ascertained from different regions of Punjab, Pakistan. Audiom-
etery was performed on a few members from each family to
determine the level of hearing loss.
Blood samples were collected in EDTA containing vacutainers.
DNA extraction from these samples was carried out using a
standard phenol-chloroform/organic method [11]. Microsatellite
markers were analyzed as described previously [12] and Sanger
sequencing was performed according to Schraders et al. [13].
Primers were designed using Primer3 software (URL: http://www.
bioinformatics.nl/cgi-bin/primer3plus/primer3plus.cgi/; [14]). Prim-
er sequences are available upon request. PCR was performed using
standard conditions.
Prior to whole genome single nucleotide polymorphism (SNP)
mapping all families were pre-screened for mutations in GJB2 by
Sanger sequence analysis. For the MYO15A locus, microsatellite
markers (D17S1843, D17S2196, D17S783 and D17S1824) were
genotyped and in families in which haplotype analysis showed
compatibility with genetic linkage, Sanger sequence analysis was
performed for MYO15A. For family 11DF, microsatellite markers
(D9S166, D9S1806 and D9S1876) were used for exclusion of the
TMC1 region.
Families with no identified mutation in GJB2 and MYO15A
were further genotyped using the Illumina HumanOmniExpress
whole genome single nucleotide polymorphism (SNP) microarray
(.700 K SNPs) or the Illumina Human Linkage-12 panel
according to the manufacturer’s protocols. Homozygosity map-
ping was performed using an online tool Homozygosity Mapper
(URL: http://www.homozygositymapper.org; [15]). The loga-
rithm of odds (LOD) score for the homozygous regions identified
in family DFR18 was calculated using the Gene Hunter v2.1r5
program in the easyLINKAGE plus v5.08 software package [16].
The exons and exon-intron boundaries of the known candidate
genes (BSND (NM_057176.2), GJB2 (NM_004004.5), HGF
(NM_000601), MYO15A (NM_016239.3), MSRB3 (NM_001031679.2),
SLC26A4 (NM_000441.1), TMC1 (NM_138691.2), TMPRSS3
(NM_024022.2) and TMIE (NM_147196)) present in the homozy-
gous regions were sequenced in the proband of the families.
Segregation analyses for identified mutations in the correspond-
ing families were performed by Sanger sequencing except for
family DFR24 and DFR18. In these families, the segregation of
TMPRSS3 and MSRB3 mutations was analyzed with restriction
digestion with the enzymes AciI and TseI, respectively (New
England Biolabs Inc. UK).
Eighty nine ethnically matched controls were sequenced for the
novel mutations identified in the current study. Control panel
screening of GJB2 (c.598G.A); MYO15A (c.9948G.A), (c.3866+
1G.A), (c.8767C.T), (c.8222 T.C); TMC1 (c.362+18A.G) and
BSND (c.97G.C), variants was done by sanger sequencing. While
for TMPRSS3 (c.726C.G) and MSRB3 (c.20T.G) variants AciI
and TseI PCR-RFLP were performed, respectively.
In silico prediction of the identified variants
In silico prediction of the identified variants was performed using
online prediction tools. Sorting intolerant from tolerant (SIFT:
http://sift.jcvi.org; [17]) and Polymorphism Phenotyping v2
(PolyPhen-2: http://genetics.bwh.harvard.edu/pph2; [18]) were
used for analyses of missense changes. Effects on splicing were
evaluated with NetGene2 (http://www.cbs.dtu.dk/services/
NetGene2/; [19]). SignalP 4.0 (http://www.cbs.dtu.dk/services/
SignalP-4.0/) was employed to predict the presence and location
of the signal peptide/non-signal peptide cleavage sites [20]. In
addition, the online tool, Have your Protein Explained (HOPE)
(http://www.cmbi.ru.nl/hope/input) was used to predict the three
dimensional structural changes at the protein level [21]. The
exome variant server (EVS) and an in-house exome database
(Human Genetics, Radboud University Medical Centre) were also
searched for the presence of putative pathogenic variants.
Minigene Construction and Splicing Assay (for c.362+
18A.G mutation in TMC1 and c.9948G.A mutation in
MYO15A)
A plasmid containing the genomic region encompassing exons
3–5 of RHO inserted at the EcoRI/SalI sites in the pCI-NEO
vector was used for in vivo splicing assays [22]. The plasmid was
adapted from the Gateway cloning technology (Life technologies)
according to the manufacturer’s protocol. PCR amplified
fragments of wild-type and mutant TMC1 exon 8, along with
flanking intronic sequences were generated with the following
primers, 59-GGGGACAAGTTTGTACAAAAAAGCAGGCTT-
Ctgggtcctaatgttgactgc-39 and 59-GGGGACCACTTTGTACAA-
GAAAGCTGGGTCggatttagaaaatcaatatcaggg-39, that contain
the attB1 and attB2 sites necessary for Gateway cloning. Similarly,
amplified fragments of wild-type and mutant MYO15A exon 61
were generated using primers, 59- GGGGACAAGTTTGTA-
CAAAAAAGCAGGCTTCttccccaggagaaatggag-39 and 59- GGG-
GACCACTTTGTACAAGAAAGCTGGGTCcagcttgctgggaag-
Hearing Loss Gene Mutations in Pakistani Families
PLOS ONE | www.plosone.org 2 June 2014 | Volume 9 | Issue 6 | e100146
gac-39. Recombinant vectors were employed for transfection of
HEK293T cells that were incubated at 37uC for 24 hours. RNA
was then isolated from the transfected cells and reverse
transcribed into cDNA and sequenced. Forward primer 59-
cggaggtcaacaacgagtct-39 and reverse primer 59-aggtgtaggggatgg-
gagac-39 were used to amplify and sequence the amplified
cDNA fragments along with flanking RHO sequences as present
in the vector.
Results
All families in this study were consanguineous (Table S1) and all
patients in these families were diagnosed with severe to profound
congenital hearing loss. Causal mutations were identified in all 30
families and the 9 novel mutations identified in the current study
were not present in any of the 89 ethnically matched control
individuals.
Sequence analysis of GJB2 in the current cohort identified 16
families with mutations in this gene (Table 1; Table 2) segregating
with hearing loss. A recurrent nonsense mutation c.71G.A
(p.Trp24*) was the most common and was found in 5 families
(31%), followed by another nonsense variant, c.231G.A
(p.Trp77*) that was identified in 4 families (25%; Table 1). In
addition to the 6 recurrent GJB2 mutations, a novel homozygous
change c.598G.A (p.Gly200Arg) was found in one consanguin-
eous family DFR10 (Table 2); as predicted by the HOPE server
the larger side chain of the mutant residue arginine might well
affect the proper folding of the cysteine rich domain. In addition,
the residue resides in the conserved region of the protein (Figure 1;
Figure S1A).
Out of the 9 novel mutations (Table 2) identified in the current
study, 4 were present in MYO15A, of which 2 were splice site
mutations (c.9948G.A and c.3866+1G.A), one was a nonsense
(c.8767C.T) and one a missense mutation (c.8222 T.C). The
c.9948G.A variant changes the last nucleotide of exon 61 and is
predicted to affect the splice donor site. The splice donor site in the
reference sequence has a highly confident score of 94%, which is
reduced to a score of 24% in the mutant. To determine the effect
of the c.9948G.A mutation on splicing, a minigene approach was
used. This showed correct splicing of the wildtype MYO15A exon
61, while the c.9948G.A mutation almost completely abolished
the normal splicing (Figure 2). NetGene2 predicted the abolition of
the splice donor site of exon 5 as a result of the c.3866+1G.A
mutation in intron 5 of MYO15A. The nonsense mutation
c.8767C.T (p.Arg2923*) was novel and predicted to lead to the
synthesis of a truncated protein, while the missense mutation
c.8222 T.C, leads to the substitution of serine for phenylalanine
(p.Phe2741Ser) at amino acid position 2741 that resides in the
conserved region of the protein (Figure 1; Figure S1B). This
missense change was predicted to be deleterious by SIFT and
Polyphen2 (Table 2).
Haplotype analysis of STR-markers flanking TMC1 showed
compatibility with genetic linkage for family 11DF. Since sequence
analysis of TMC1 revealed a novel intronic mutation, c.362+18A.
G, this family was not further analyzed by SNP-array genotyping.
The variant segregated with the hearing loss in the family (Figure 1)
and was predicted to create a novel splice donor site with a similar
confidence score as the original splice donor site. To determine the
effect of the c.362+18A.G mutation on splicing, a minigene
approach was used. This revealed correct splicing of the wild-type
TMC1 exon 8, while the c.362+18A.G mutation resulted in a
17 bp extension of exon 8 (Figure 3). This leads to a frameshift and
a premature stop codon (p.Glu122Tyrfs*10).
A novel homozygous missense mutation was identified in
TMPRSS3 (MIM_605511), c.726C.G (p.Cys242Trp) that co-
segregated with hearing impairment in family DFR24 (Figure 1)
and was predicted to be probably damaging by Polyphen2 and
deleterious by SIFT (Table 2). This mutation is located in the
peptidase S1 domain and the HOPE server predicted the abolition
of the catalytic activity of TMPRSS3. In addition the amino acid
substitution is present in a region of the protein that is conserved
across different species (Figure S1D) and therefore probably affects
the core structure of the peptidase domain (Figure 4).
In family DFR18 SNP microarray data analysis revealed a
17.6 Mb homozygous region on chromosome 12 flanked by SNPs
rs7978381 and rs7976686, a LOD score of 2.7 was calculated for
this region. The known deafness gene, MSRB3 (MIM_613719), in
the region was subsequently sequenced, revealing a novel
homozygous nucleotide substitution c.20T.G (p.Leu7Arg) in
exon 4 (Figure 1; Table 2). The leucine at position 7 is located in
the signal peptide of the MSRB3 protein and as a result of the
substitution by arginine this signal peptide loses its function as
predicted by SignalP 4.0. Furthermore, the Leu7 residue is
conserved across species (Figure S1E). The mutation abolishes a
TseI restriction site, which allowed the segregation of this variant in
the family to be checked by restriction digestion. By using the same
analysis, this variant was also found heterozygously in 3 out of 178
ethnically matched control alleles.
The novel BSND (MIM_606412) missense mutation c.97G.C
(p.Val33Leu) in family 7DF (Figure 1) was predicted to be
deleterious by SIFT and Polyphen2 (Table 2) and Val33 is
conserved across species (Figure S1C).
Table 1. Spectrum of recurrent GJB2 mutations in Pakistani families with autosomal recessive non-syndromic hearing loss
(ARNSHL).
Mutation identified (Protein change) Type of mutation
No. of
families
No. of affected
members Frequency in EVS
c.71G.A (p.Trp24*) Nonsense (homozygous) 5 26 Absent
c.231G.A (p.Trp77*) Nonsense (homozygous) 4 14 AA= 0/AG= 1/GG=4299
c.35delG (p.Gly12Valfs*2) Frameshift (homozygous) 2 8 Absent
c.35delG (p.Gly12Valfs*2) c.439G.A (p.Glu147Lys) Missense (compound heterozygous) 1 3 Absent
c.380G.A (p.Arg127His)# Missense (homozygous) 2 4 AA= 0/AG= 26/GG=4274
c.377_378insATGCGGA (p.Arg127Cysfs*85) Frameshift (homozygous) 1 2 Absent
As reference sequence NM_004004.5 was employed. EVS, exome variant server;
#The pathogenicity of this mutation is controversial.
doi:10.1371/journal.pone.0100146.t001
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Figure 1. Pedigrees and the segregation of novel mutations in known deafness genes. Unfilled circles indicate unaffected females, unfilled
squares indicate unaffected males, filled circles indicate affected females, filled squares indicate affected males, double lines represent
consanguineous marriages, slashed line across the symbols indicate deceased individual, + indicates wild type allele, M indicates mutant allele.
doi:10.1371/journal.pone.0100146.g001
Hearing Loss Gene Mutations in Pakistani Families
PLOS ONE | www.plosone.org 5 June 2014 | Volume 9 | Issue 6 | e100146
Recurrent mutations in TMC1 (c.1114G.A; p.Val372Met [23]
and c.100C.T; p.Arg34* [24]), HGF (c.482+1991_2000delGAT-
GATGAAA and c.482+1986_1988delTGA [25]), SLC26A4
(c.1337A.G; p.Gln446Arg [26]) and TMIE (c.241C.T;
p.Arg81Cys [27]) also segregated in the respective families and
most likely are the disease causing mutations (Table 3).
Figure 2. Effect of MYO15A c. 9948G.A using a minigene approach. An agarose gel containing RT-PCR products detected from HEK293T
cells transfected with the wildtype and mutant minigene construct and a schematic representation of the identified splicing products. The RT-PCR
products were verified by sequence analysis. The c.9948G.A mutation leads to skipping of exon 61.
doi:10.1371/journal.pone.0100146.g002
Figure 3. Effect of TMC1 intronic mutation c.362+18A.G using a minigene approach. Electropherogram of the partial cDNA sequence of
RNA derived from cells transfected with the pCI-NEO with either the mutant or wildtype TMC1 exon 8. The mutation leads to the insertion of 17bp at
the 39end of exon 8, which can be predicted to result in a premature stop codon in exon 9 (p.Glu122Tyrfs*10).
doi:10.1371/journal.pone.0100146.g003
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Discussion
In a cohort of 30 ARNSHL families the genetic defects were
identified in 9 known deafness genes; GJB2, MYO15A, TMC1,
BSND, TMPRSS3, MSRB3, HGF, SLC26A4 and TMIE. In the
current panel recurrent as well as novel mutations were detected,
the novel mutations were identified in GJB2, MYO15A, TMC1,
BSND, TMPRSS3 and MSRB3.
GJB2 was the most frequently mutated gene in these families. In
this gene the novel mutation c.598G.A (p.Gly200Arg) affects a
residue in the cysteine-rich domain that is involved in the
formation of intramolecular disulphide bonds [28,29]. Although
the effect of glycine on the intramolecular disulphide bond
formation cannot be predicted, the mutant residue arginine may
affect the proper folding of the cysteine-rich domain because of the
larger size of the arginine side chain.
In two families the GJB2 variant c.380G.A (p.Arg127His) was
found to segregate with the hearing loss, being present homozy-
gously in 4 affected members. Other studies have also reported
deafness patients carrying this mutation homozygously [29,30,31].
Based upon the higher carrier frequency in patients as well as
controls, Padma et al. [30] suggested that it is unlikely that this
variant plays a pathogenic role in deafness. However, Matos et al.
[32] have proposed that this mutation is likely to be pathogenic
when influenced by other unknown genetic or environmental
factors [32]. In the EVS, however, no homozygous occurrence of
the mutated allele has been reported to date (Table S1).
Identification of 4 p.Arg127His homozygous patients out of 125
deafness patients in the current study and the previously reported
cases of 9 heterozygous cases and 1 compound heterozygous case
in 70 deaf patients by Bukhari et al. [31], demonstrates that this is
the most frequently occurring mutation in Pakistani deafness
families and therefore becomes important in genetic counseling of
Pakistani deaf patients.
In the current study GJB2 mutations were found to be the most
common, followed by MYO15A mutations. The overall frequency
of the two most common nonsense variants c.71G.A (p.Trp24*)
and c.231G.A (p.Trp77*) of GJB2 in Pakistani deafness patients
was obtained from the current (n = 125) as well as previously
reported studies of Santos et al. [33] (n = 430) and Bukhari et al.
[31] (n = 70). Using these data, the frequency was found to be
5.9% (p.Trp24*) and 4.3% (p.Trp77*) [31,33]. The variant
p.Trp24* has a high prevalence in the Indian population as well
[34], Pakistan and India have a shared genetic ancestry [35],
which could be the reason of the presence of this variant in both
populations. The third mutation p.Gly12Valfs*2 identified in the
current study has previously been reported from Northern areas of
Pakistan [31] and also in Caucasians and Turks [36], thus
indicating a possible founder effect of this mutation. In the current
cohort, 35% (60/173) individuals were found to be carriers of
GJB2 mutations. Therefore, as a preliminary screening of deaf
families the sequencing of this gene is suggested in Pakistan. In the
current study MYO15A was found to be the second leading cause
of deafness in the Pakistani population, but still no recurrent
mutation was identified in this gene.
A total of 7 nonsense mutations were identified in GJB2,
MYO15A and TMC1, these nonsense mutations are likely to cause
nonsense mediated decay (NMD) because they are either present
in the middle or near the 59end of the gene.
InMYO15A two splice site, a nonsense and a missense mutations
were identified. The c.9948G.A (p.Gln3316Gln) mutation affects
the last nucleotide of exon 61 and changes the consensus splice site
sequence. Based on the results of the minigene assay the
c.9948G.A mutation is expected to lead to skipping of exon 61,
which would result in a frameshift and NMD can be expected to
occur at least for part of the mRNAs. The second splice site
mutation c.3866+1G.A is a canonical splice site change and is
predicted to remove the splice donor site of exon 5. An alternative
splice site is predicted at position +99 in intron 5, if this alternative
site is used it would lead to a frameshift and a premature stop
codon (encoded by nucleotide 2–4 of intron 5). Both splice site
mutations are thus predicted to lead to a frameshift and NMD
could occur for at least part of the mRNA transcripts. The two
other novel mutations, c.8222T.C (p.Phe2741Ser) and
c.8767C.T (p.Arg2923*), found in two different families, are
located in the region of the gene that encodes the tail region of
MYO15A and are likely to cause a loss of function of this region.
The p.Arg2923* mutation is present in the SH3 domain, which is
involved in the protein-protein interactions [37]. Most of the
previously reported mutations of MYO15A causing congenital
severe to profound deafness were found in the motor head and the
tail domains [6,38]. Collectively these results indicate that the
motor head and tail regions of MYO15A are essential in the
hearing process and any mutation in these regions is thus critical
[39].
TMC1 encoding a transmembrane protein is expressed in the
neurosensory hair cells of the mouse cochlea [40]. The recurrent
nonsense mutation in exon 7 of TMC1, c.100C.T (p.Arg34*) is
Figure 4. Predicted effect of mutation c.726C.G (p.Cys242Trp) on the three dimensional structure of TMPRSS3. A) Wild type protein
structure with an intact disulphide bridge showing position of the mutated residue (magenta). B) Close-up view of the structure showing the wild
type residue cysteine (green) and the mutant residue tryptophan (red). In case of the mutant residue there will be no disulphide bridge at this
position.
doi:10.1371/journal.pone.0100146.g004
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the most common TMC1mutation reported in Pakistan. It leads to
a truncated protein and leads to congenital severe to profound
hearing loss [40,41,42,43]. Ben Said et al. [42] have previously
described that the p.Arg34* is an old founder mutation found in
several populations including the Pakistani population. It is likely
that the family described here carries the mutation on the founder
haplotype. Also a novel intronic mutation in the TMC1 gene,
c.362+18A.G was identified in the current study (Table 2), which
creates a novel splice donor site and the insertion of 17 nucleotides
as demonstrated in the minigene approach.
BSND encodes the barttin protein, which is a vital subunit of the
chloride and voltage-sensitive Ka (CLCNKA) and Kb (CLCNKB)
channels in the inner ear and the kidney. Chloride channels and
the barttin protein form heteromers which function in the
recycling of the K+ ions in the inner ear and salt reabsorption in
the kidneys [44,45,46,47,48,49]. As predicted by in silico analysis,
the currently identified BSND mutation p.Val33Leu residing in the
transmembranal region might result in the malfunctioning of
chloride channels CLCNKA and CLCNKB. However, in the
current family there were no complaints of any renal problems.
Deafness caused by mutations in the TMPRSS3 gene is bilateral
and severe to profound with no defects of the middle ear and the
vestibular system [50]. Mutations in TMPRSS3 can also cause
progressive hearing loss with a postlingual onset [51]. TMPRSS3
mutation c.726C.G (p.Cys242Trp) in exon 8 affects the serine
protease domain as predicted by 3D modeling. Previously another
mutation in the same exon of TMPRSS3, c. 647G.T (p.Ar-
g216Leu) has been shown to result in a failure of the protein to
undergo proteolytic cleavage resulting in the inactivation of the
sodium channel [52].
The homozygous variant p.Leu7Arg (c.20T.G) in MSRB3
identified in the current study is located in the mitochondrial
signal sequence and may result in mislocalization of the protein.
Ahmed et al. [53] have shown the importance of the mitochon-
drial isoforms when they found a mutation c.55T.C (p.Arg19*) to
underlie hearing impairment. This mutation also resides in the
signal sequence for mitochondrial localization. However, the
variant c.20T.G (p.Leu7Arg) was also found in heterozygous
state in 3 out of 89 (1.7%) ethnically matched controls. The
mutation might be a founder mutation in the corresponding
population. However, currently it is uncertain whether this variant
is the cause of hearing impairment in the family and further studies
are necessary for a definite conclusion on the pathogenic effect of
the variant.
Conclusions
In the present study 53% (16/30) of the families were found to
carry causative mutations in GJB2 illustrating that the most
frequently involved gene in deafness in the Pakistani population is
GJB2 followed by MYO15A (13%, 4/30) and TMC1 (10%, 3/30).
Based on these results it is therefore suggested that as an initial step
for the genetic diagnosis of deafness, GJB2 should be analyzed in
Pakistani patients and if this gene is excluded then microsatellite
markers flanking MYO15A and TMC1 should be genotyped to
exclude those genes or to indicate mutation analysis. Homozy-
gosity mapping is an effective approach to determine the mutated
genes in consanguineous families. Although a large number of
deafness genes and mutations have already been identified, our
study demonstrates that the full mutation spectrum in these genes
is still not defined. Identification of novel mutations in these genes
is important for genetic counseling and can provide handles for
further studies on protein function. Genetic counseling of the
families is important to better inform couples about the risk of their
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offspring to be hearing impaired. In addition, as can be seen in the
current study, recurrent as well as novel mutations in known genes
define the disease in the families which seem to have some
population specificity. This information can be important in
developing screening strategies.
Supporting Information
Figure S1 Multiple-alignment of the corresponding
stretches of protein sequences across different species.
The blue color shading represents the intensity of conservation,
where the dark blue shading represents highly conserved stretch
while the light blue shading denotes moderate conservation of
residues across different species. A) Amino acid sequence
conservation of p.Gly200 across 9 species. B) Amino acid sequence
conservation of p.Phe2741 across 11 species. C) Amino acid
sequence conservation of p.Val33 across 7 species. D) Amino acid
sequence conservation of p.Cys24 across 10 species. E) Non-
conserved residue of p.Leu7 across 10 species.
(TIF)
Table S1 Characteristics of 30 Pakistani families
diagnosed with autosomal recessive non-syndromic
hearing loss (ARNSHL).
(DOC)
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